Prevalence of autoimmune pancreatitis in pancreatic resection for suspected malignancy: a systematic review and meta-analysis

Abstract Background/Objectives Autoimmune pancreatitis (AIP) is a diagnosis-challenging disease that often mimics pancreatic malignancy. Pancreatic resection is considered to be a curative treatment for pancreatic ductal adenocarcinoma (PDAC). This meta-analysis aims to study the incidence of AIP in...

Full description

Saved in:
Bibliographic Details
Main Authors: Zain A. Karamya, Attila Kovács, Dóra Illés, Bálint Czakó, Alíz Fazekas, Nelli Farkas, Péter Hegyi, László Czakó
Format: Article
Language:English
Published: BMC 2024-08-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-024-03367-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846158444170575872
author Zain A. Karamya
Attila Kovács
Dóra Illés
Bálint Czakó
Alíz Fazekas
Nelli Farkas
Péter Hegyi
László Czakó
author_facet Zain A. Karamya
Attila Kovács
Dóra Illés
Bálint Czakó
Alíz Fazekas
Nelli Farkas
Péter Hegyi
László Czakó
author_sort Zain A. Karamya
collection DOAJ
description Abstract Background/Objectives Autoimmune pancreatitis (AIP) is a diagnosis-challenging disease that often mimics pancreatic malignancy. Pancreatic resection is considered to be a curative treatment for pancreatic ductal adenocarcinoma (PDAC). This meta-analysis aims to study the incidence of AIP in patients who have undergone pancreatic resection for clinical manifestation of cancer. Methods A comprehensive search was conducted in three databases, PubMed, Embase and the Cochrane Library, using the terms ‘autoimmune pancreatitis’ and ‘pancreatic resection’ and supplemented by manual checks of reference lists in all retrieved articles. Results Ten articles were included in the final analysis. 8917 pancreatic resections were performed because of a clinical suspicion of pancreatic cancer. AIP accounted for 140 cases (1.6%). Type 1 AIP comprised the majority of cases, representing 94% (132 cases), while type 2 AIP made up the remaining 6% (eight cases) after further classification. AIP accounted for almost 26% of all cases of benign diseases involving unnecessary surgery and was overrepresented in males in 70% of cases compared to 30% in females. The mean age for AIP patients was 59 years. Serum CA 19 − 9 levels were elevated in 23 out of 47 (49%) AIP patients, where higher levels were detected more frequently in patients with type 1 AIP (51%, 22 out of 43) than in those with type 2 AIP (25%, 1 out of 4). The sensitivity of IgG4 levels in type 1 AIP was low (43%, 21/49 patients). Conclusion Even with modern diagnostic methods, distinguishing between AIP and PDAC can still be challenging, thus potentially resulting in unnecessary surgical procedures in some cases. Serum CA 19 − 9 levels are not useful in distinguishing between AIP and PDAC. Work must thus be done to improve diagnostic methods and avoid unnecessary complicated surgery.
format Article
id doaj-art-41c87ee4f18f4615a2f0aac44a057089
institution Kabale University
issn 1471-230X
language English
publishDate 2024-08-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj-art-41c87ee4f18f4615a2f0aac44a0570892024-11-24T12:28:33ZengBMCBMC Gastroenterology1471-230X2024-08-0124111110.1186/s12876-024-03367-9Prevalence of autoimmune pancreatitis in pancreatic resection for suspected malignancy: a systematic review and meta-analysisZain A. Karamya0Attila Kovács1Dóra Illés2Bálint Czakó3Alíz Fazekas4Nelli Farkas5Péter Hegyi6László Czakó7Division of Gastroenterology, Department of Medicine, University of SzegedDepartment of Gastroenterology and Internal Medicine, Markusovszky Teaching HospitalDivision of Gastroenterology, Department of Medicine, University of SzegedDivision of Gastroenterology, Department of Medicine, University of SzegedInstitute for Translational Medicine, Medical School, University of PécsInstitute of Bioanalysis, Medical School, University of PécsDivision of Pancreatic Diseases, Heart and Vascular Centre, Semmelweis UniversityDivision of Gastroenterology, Department of Medicine, University of SzegedAbstract Background/Objectives Autoimmune pancreatitis (AIP) is a diagnosis-challenging disease that often mimics pancreatic malignancy. Pancreatic resection is considered to be a curative treatment for pancreatic ductal adenocarcinoma (PDAC). This meta-analysis aims to study the incidence of AIP in patients who have undergone pancreatic resection for clinical manifestation of cancer. Methods A comprehensive search was conducted in three databases, PubMed, Embase and the Cochrane Library, using the terms ‘autoimmune pancreatitis’ and ‘pancreatic resection’ and supplemented by manual checks of reference lists in all retrieved articles. Results Ten articles were included in the final analysis. 8917 pancreatic resections were performed because of a clinical suspicion of pancreatic cancer. AIP accounted for 140 cases (1.6%). Type 1 AIP comprised the majority of cases, representing 94% (132 cases), while type 2 AIP made up the remaining 6% (eight cases) after further classification. AIP accounted for almost 26% of all cases of benign diseases involving unnecessary surgery and was overrepresented in males in 70% of cases compared to 30% in females. The mean age for AIP patients was 59 years. Serum CA 19 − 9 levels were elevated in 23 out of 47 (49%) AIP patients, where higher levels were detected more frequently in patients with type 1 AIP (51%, 22 out of 43) than in those with type 2 AIP (25%, 1 out of 4). The sensitivity of IgG4 levels in type 1 AIP was low (43%, 21/49 patients). Conclusion Even with modern diagnostic methods, distinguishing between AIP and PDAC can still be challenging, thus potentially resulting in unnecessary surgical procedures in some cases. Serum CA 19 − 9 levels are not useful in distinguishing between AIP and PDAC. Work must thus be done to improve diagnostic methods and avoid unnecessary complicated surgery.https://doi.org/10.1186/s12876-024-03367-9Autoimmune pancreatitisPancreaticoduodenectomyPancreatic cancerPancreatic resectionIgG4Whipple’s procedure
spellingShingle Zain A. Karamya
Attila Kovács
Dóra Illés
Bálint Czakó
Alíz Fazekas
Nelli Farkas
Péter Hegyi
László Czakó
Prevalence of autoimmune pancreatitis in pancreatic resection for suspected malignancy: a systematic review and meta-analysis
BMC Gastroenterology
Autoimmune pancreatitis
Pancreaticoduodenectomy
Pancreatic cancer
Pancreatic resection
IgG4
Whipple’s procedure
title Prevalence of autoimmune pancreatitis in pancreatic resection for suspected malignancy: a systematic review and meta-analysis
title_full Prevalence of autoimmune pancreatitis in pancreatic resection for suspected malignancy: a systematic review and meta-analysis
title_fullStr Prevalence of autoimmune pancreatitis in pancreatic resection for suspected malignancy: a systematic review and meta-analysis
title_full_unstemmed Prevalence of autoimmune pancreatitis in pancreatic resection for suspected malignancy: a systematic review and meta-analysis
title_short Prevalence of autoimmune pancreatitis in pancreatic resection for suspected malignancy: a systematic review and meta-analysis
title_sort prevalence of autoimmune pancreatitis in pancreatic resection for suspected malignancy a systematic review and meta analysis
topic Autoimmune pancreatitis
Pancreaticoduodenectomy
Pancreatic cancer
Pancreatic resection
IgG4
Whipple’s procedure
url https://doi.org/10.1186/s12876-024-03367-9
work_keys_str_mv AT zainakaramya prevalenceofautoimmunepancreatitisinpancreaticresectionforsuspectedmalignancyasystematicreviewandmetaanalysis
AT attilakovacs prevalenceofautoimmunepancreatitisinpancreaticresectionforsuspectedmalignancyasystematicreviewandmetaanalysis
AT dorailles prevalenceofautoimmunepancreatitisinpancreaticresectionforsuspectedmalignancyasystematicreviewandmetaanalysis
AT balintczako prevalenceofautoimmunepancreatitisinpancreaticresectionforsuspectedmalignancyasystematicreviewandmetaanalysis
AT alizfazekas prevalenceofautoimmunepancreatitisinpancreaticresectionforsuspectedmalignancyasystematicreviewandmetaanalysis
AT nellifarkas prevalenceofautoimmunepancreatitisinpancreaticresectionforsuspectedmalignancyasystematicreviewandmetaanalysis
AT peterhegyi prevalenceofautoimmunepancreatitisinpancreaticresectionforsuspectedmalignancyasystematicreviewandmetaanalysis
AT laszloczako prevalenceofautoimmunepancreatitisinpancreaticresectionforsuspectedmalignancyasystematicreviewandmetaanalysis